Disclosures for "The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease"
-
Dr. Arfaie has received publishing royalties from a publication relating to health care.
-
Mr. Aumont has nothing to disclose.
-
Mr. Therriault has nothing to disclose.
-
Miss Kwan has nothing to disclose.
-
Miss Carello Collar has nothing to disclose.
-
Mr. Hall has nothing to disclose.
-
Mr. Ferrari Souza has nothing to disclose.
-
Dr. Woo has nothing to disclose.
-
Dr. CASSA MACEDO has received research support from Alzheimer Society of Canada. Dr. CASSA MACEDO has received research support from McGill University.
-
Author has nothing to disclose
-
Ms. Trudel has nothing to disclose.
-
Miss Rahmouni has nothing to disclose.
-
Dr. Servaes has nothing to disclose.
-
Dr. Vitali has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Vitali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novonordisk. Dr. Vitali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Vitali has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BTX.
-
Dr. Soucy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Canada. Dr. Soucy has received research support from CIHR. Dr. Soucy has a non-compensated relationship as a Associate with Weston Foundation that is relevant to AAN interests or activities.
-
Dr. Pascoal has nothing to disclose.
-
Dr. ZIMMER has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVO NORDISK. Dr. ZIMMER has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NEXT INNOVATIVE THERAPEUTICS. Dr. ZIMMER has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MASIMA. Dr. ZIMMER has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVO NORDISK. Dr. ZIMMER has stock in MASIMA. The institution of Dr. ZIMMER has received research support from ALZHEIMERS ASSOCIATION. The institution of Dr. ZIMMER has received research support from CNPQ. The institution of Dr. ZIMMER has received research support from FAPERGS. The institution of Dr. ZIMMER has received research support from BRAZILIAN MINISTRY OF HEALTH. The institution of Dr. ZIMMER has received research support from SERRAPILHEIRA INSTITUTE . The institution of Dr. ZIMMER has received research support from NATIONAL ACADEMY OF NEUROPSYCHOLOGY.
-
Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
-
Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.